Methylphenidate therapy, headaches and caffeine consumption

Journal of Clinical Psychopharmacology

Volumn 33, Issue 1, 2013, Pages 148-

  Musafia, Boaz ^a   Rosenberg, Gilad ^b  

^a BioVent Ltd   (Israel)

^b D Pharm Ltd   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; METHYLPHENIDATE;

AROUSAL; ATTENTION DEFICIT DISORDER; COFFEE; COGNITION; DRUG INDUCED HEADACHE; DRUG SAFETY; FOOD INTAKE; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 85027923716     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/01.jcp.0000426192.98855.59     Document Type: Letter

References (4)

1. Adler LA, Orman C, Starr HL, et al. Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study. J Clin Psychopharmacol. 2011;31:108-114.
2. Walker LR, Abraham AA, Tercyak KP. Adolescent caffeine use, ADHD, and cigarette smoking. Children's Health Care. 2010;39:73-90.
3. Dosh T, Helmbrecht T, Anestis J, et al. A comparison of the associations of caffeine and cigarette use with depressive and ADHD symptoms in a sample of young adult smokers. J Addict Med. 2010;4: 52-54.
4. Fennelly M, Galletly DC, Purdie GI. Is caffeine withdrawal the mechanism of postoperative headache? Anesth Analg. 1991;72:449-453.